Monday, July 2, 2007

AMKR Continues to Power Gains in Portfolio A1

With another week of strong gains, Amkor (AMKR) now has logged a cumulative gain of 33% since Portfolio A1 began 4 ½ months ago.

Weakness across the balance of the portfolio – with the notable exception of Terex (TEX) – has resulted in the portfolio underperforming the S&P 500 benchmark over the course of the past two months. For the full life of the portfolio, the gains of 4.8% continue to better the S&P 500, but by a margin that has slipped to 1.5%.

I should note that with the fractional losses of the two holdings added last week, Portfolio A1 now has had a total of four winning trades and eight losing trades to date. This is important because the intent of this portfolio is not to aim for a high percentage of winners by hitting a lot of singles, but to seek out doubles, triples and home runs, with the expectation that there will be many instances in which the portfolio is stopped out of losing trades. Based on past performance of similar portfolios, my guess is that it will probably take a year or two before this approach is evident from the portfolio statistics.

There are no changes to the portfolio for the coming week.

A snapshot of the portfolio is as follows:


DISCLAIMER: "VIX®" is a trademark of Chicago Board Options Exchange, Incorporated. Chicago Board Options Exchange, Incorporated is not affiliated with this website or this website's owner's or operators. CBOE assumes no responsibility for the accuracy or completeness or any other aspect of any content posted on this website by its operator or any third party. All content on this site is provided for informational and entertainment purposes only and is not intended as advice to buy or sell any securities. Stocks are difficult to trade; options are even harder. When it comes to VIX derivatives, don't fall into the trap of thinking that just because you can ride a horse, you can ride an alligator. Please do your own homework and accept full responsibility for any investment decisions you make. No content on this site can be used for commercial purposes without the prior written permission of the author. Copyright © 2007-2023 Bill Luby. All rights reserved.
Web Analytics